Safety and Preliminary Effectiveness of BGB-A445 in Combination With Tislelizumab in Participants With Advanced Solid Tumors

Clinical trial NCT04215978 · COMPLETED

Trial details

NCT number: NCT04215978
Sponsor: BeiGene
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Non Small Cell Lung Cancer Head and Neck Squamous Cell Carcinoma (HNSCC)Nasopharyngeal Carcinoma (NPC)

Start date: 2020-01-30
Primary completion: 2025-01-24
Enrollment: 204

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.